Increased levels of soluble IL-1RII have been found in the synovial fluid (39) and plasma of individuals with RA (78), and these negatively correlated with severity of disease, suggesting IL-1RII acts as natural antagonist of IL-1-driven joint destruction. The gene discussed is IL1A; the disease is rheumatoid arthritis.